课题基金 / 基金详情

Ecstasy, methamphetamine and their combination: Assessment of adverse effects

Ecstasy, methamphetamine and their combination: Assessment of adverse effects
摇头丸、甲基苯丙胺及其组合:不良反应评估
批准号:
nhmrc : 352475
负责人:
A/Pr Glenn Hunt
金额:
$25.62万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2005
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2005-01-01 至 2007-12-31

项目摘要

项目成果

A/Pr Glenn Hunt的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
MDMA (Ecstasy) and Methamphetamine (METH) are popular party drugs that are frequently used by young Australians. Health problems associated with MDMA and METH use are (1) many people suffer complications arising from the high body temperature (hyperthermia) that these drugs produce, and (2) MDMA and METH may both cause long-term loss of key neurotransmitters in the brain. This effect on the brain may well lead to psychological problems such as anxiety, depression, increased impulsive behaviour and memory impairment. However the link between MDMA and METH use and subsequent brain damage is still very controversial. Recently, we have found that when MDMA and METH are combined, a particularly toxic effect is seen with very high body temperatures and lasting adverse effects on mood and brain function. This is a major cause for concern because of evidence that many Australian drug users are combining METH and MDMA on a regular basis. This project will investigate the short and long-term effects of MDMA, METH and METH-MDMA combinations. Phase 1 is aimed at investigating whether different doses of the drugs lead to lasting changes in mood, behaviour and brain function and to compare the relative toxicity of the three treatments. Phase 2 will determine whether lack of fluid intake, high environmental temperatures and advanced age are risk factors in determining the toxicity of MDMA and METH. Phase 3 will assess whether the toxicity of these drug treatments depends upon whether an animal takes the drugs voluntarily or whether they are injected with the drug by the experimenter. The final part of the project will use a wide variety of advanced techniques to track the brain damage caused by these drug treatments given under a range of conditions. The significance of this project will be in increasing our understanding of how MDMA and METH affect the brain and behaviour and how the harms posed by these drugs may be predicted and therefore minimised.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel therapeutics for the remediation of social deficits in psychiatric illness
  • 批准号:
    nhmrc : GNT1088711
  • 项目类别:
    Project Grants
  • 资助金额:
    $57.95万
  • 财政年份:
    2015
  • 负责人:
    A/Pr Glenn Hunt
  • 依托单位:
Novel therapeutics for the remediation of social deficits in psychiatric illness
  • 批准号:
    nhmrc : 1088711
  • 项目类别:
    Project Grants
  • 资助金额:
    $39.86万
  • 财政年份:
    2015
  • 负责人:
    A/Pr Glenn Hunt
  • 依托单位:
A randomised controlled trial to examine the effectiveness of oxytocin to improve treatment for anorexia nervosa
  • 批准号:
    nhmrc : 1088826
  • 项目类别:
    Project Grants
  • 资助金额:
    $27.73万
  • 财政年份:
    2015
  • 负责人:
    A/Pr Glenn Hunt
  • 依托单位:
A randomised controlled trial to examine the effectiveness of oxytocin to improve treatment for anorexia nervosa
  • 批准号:
    nhmrc : GNT1088826
  • 项目类别:
    Project Grants
  • 资助金额:
    $40.29万
  • 财政年份:
    2015
  • 负责人:
    A/Pr Glenn Hunt
  • 依托单位:
海外基金